Roche says new MS drug works better than Merck's Rebif

ZURICH (Reuters) - Roche said on Wednesday its Ocrevus multiple sclerosis drug controlled the most common form of the disease better than a rival's medicine and worked against another form of MS for which there is no approved treatment.